• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群和饮食对载脂蛋白 E 基因敲除小鼠动脉粥样硬化发展的影响。

Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe Mice.

机构信息

From the Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Sahlgrenska University Hospital, University of Gothenburg, Sweden (A.L.J., R.C., R.A., C.R., F.F.H., J.B., F.B.).

Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, University of Copenhagen, Denmark (F.B.).

出版信息

Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2318-2326. doi: 10.1161/ATVBAHA.118.311233.

DOI:10.1161/ATVBAHA.118.311233
PMID:29903735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6166703/
Abstract

Objective- To investigate the effect of gut microbiota and diet on atherogenesis. Approach and Results- Here, we investigated the interaction between the gut microbiota and diet on atherosclerosis by feeding germ-free or conventionally raised Apoe mice chow or Western diet alone or supplemented with choline (which is metabolized by the gut microbiota and host enzymes to trimethylamine N-oxide) for 12 weeks. We observed smaller aortic lesions and lower plasma cholesterol levels in conventionally raised mice compared with germ-free mice on a chow diet; these differences were not observed in mice on a Western diet. Choline supplementation increased plasma trimethylamine N-oxide levels in conventionally raised mice but not in germ-free mice. However, this treatment did not affect the size of aortic lesions or plasma cholesterol levels. Gut microbiota composition was analyzed by sequencing of 16S rRNA genes. As expected, the global community structure and relative abundance of many taxa differed between mice fed chow or a Western diet. Choline supplementation had minor effects on the community structure although the relative abundance of some taxa belonging to Clostridiales was altered. Conclusions- In conclusion, the impact of the gut microbiota on atherosclerosis is dietary dependent and is associated with plasma cholesterol levels. Furthermore, the microbiota was required for trimethylamine N-oxide production from dietary choline, but this process could not be linked to increased atherosclerosis in this model.

摘要

目的-研究肠道微生物群和饮食对动脉粥样硬化形成的影响。

方法和结果-在这里,我们通过单独用无特定病原体(germ-free)或常规饲养(conventionally raised)的 Apoe 小鼠喂养标准饲料或西方饮食(Western diet),或用补充胆碱(choline,由肠道微生物群和宿主酶代谢为三甲胺 N-氧化物(trimethylamine N-oxide))的方法,研究了肠道微生物群和饮食对动脉粥样硬化的相互作用,持续 12 周。我们观察到,与标准饲料喂养的无特定病原体小鼠相比,常规饲养的小鼠主动脉病变较小,血浆胆固醇水平较低;而在西方饮食喂养的小鼠中则没有观察到这些差异。胆碱补充增加了常规饲养小鼠的血浆三甲胺 N-氧化物水平,但对无特定病原体小鼠没有影响。然而,这种处理方法并没有影响主动脉病变的大小或血浆胆固醇水平。通过 16S rRNA 基因测序分析了肠道微生物群的组成。正如预期的那样,与标准饲料或西方饮食相比,喂食 Chow 或 Western 饮食的小鼠的全球群落结构和许多分类群的相对丰度存在差异。胆碱补充对群落结构的影响较小,尽管属于梭状芽孢杆菌(Clostridiales)的某些分类群的相对丰度发生了改变。

结论-总之,肠道微生物群对动脉粥样硬化的影响取决于饮食,并与血浆胆固醇水平有关。此外,微生物群是膳食胆碱产生三甲胺 N-氧化物所必需的,但在这个模型中,这一过程与动脉粥样硬化的增加无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/c1744b3b34a0/atv-38-2318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/c5c73123a495/atv-38-2318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/d9aca3efbd8a/atv-38-2318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/99086333480a/atv-38-2318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/c1744b3b34a0/atv-38-2318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/c5c73123a495/atv-38-2318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/d9aca3efbd8a/atv-38-2318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/99086333480a/atv-38-2318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c7/6166703/c1744b3b34a0/atv-38-2318-g004.jpg

相似文献

1
Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe Mice.肠道微生物群和饮食对载脂蛋白 E 基因敲除小鼠动脉粥样硬化发展的影响。
Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2318-2326. doi: 10.1161/ATVBAHA.118.311233.
2
Dietary Choline or Trimethylamine N-oxide Supplementation Does Not Influence Atherosclerosis Development in Ldlr-/- and Apoe-/- Male Mice.饮食胆碱或三甲胺 N-氧化物补充剂不会影响 LDLR-/-和 Apoe-/-雄性小鼠的动脉粥样硬化发展。
J Nutr. 2020 Feb 1;150(2):249-255. doi: 10.1093/jn/nxz214.
3
Choline and trimethylamine N-oxide supplementation in normal chow diet and western diet promotes the development of atherosclerosis in Apoe -/- mice through different mechanisms.胆碱和三甲胺 N-氧化物补充正常饲料饮食和西方饮食通过不同的机制促进 Apoe -/- 小鼠动脉粥样硬化的发展。
Int J Food Sci Nutr. 2023 Mar;74(2):234-246. doi: 10.1080/09637486.2023.2187742. Epub 2023 Apr 4.
4
Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.胆碱和丁酸盐通过调节肠道微生物组而有益于降低 APOE*3-Leiden.CETP 小鼠的动脉粥样硬化,而不影响其发生。
Atherosclerosis. 2022 Dec;362:47-55. doi: 10.1016/j.atherosclerosis.2022.10.009. Epub 2022 Oct 19.
5
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.小檗碱通过操纵肠道微生物组抑制三甲胺和氧化三甲胺的产生来减轻胆碱诱导的动脉粥样硬化。
NPJ Biofilms Microbiomes. 2021 Apr 16;7(1):36. doi: 10.1038/s41522-021-00205-8.
6
Edgeworthia gardneri (Wall.) Meisn protects against HFD-induced murine atherosclerosis through improving gut microbiota-mediated intestinal barrier integrity.结香(Edgeworthia gardneri (Wall.) Meisn)通过改善肠道微生物群介导的肠道屏障完整性来预防高脂饮食诱导的小鼠动脉粥样硬化。
Atherosclerosis. 2025 Apr;403:119132. doi: 10.1016/j.atherosclerosis.2025.119132. Epub 2025 Feb 21.
7
Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe mice.小檗碱治疗增加了肠道内阿克曼氏菌的数量,并改善了载脂蛋白 E 基因敲除小鼠的高脂肪饮食诱导的动脉粥样硬化。
Atherosclerosis. 2018 Jan;268:117-126. doi: 10.1016/j.atherosclerosis.2017.11.023. Epub 2017 Nov 24.
8
Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e-/- Mice.产甲烷古菌肠道定植降低载脂蛋白 E 基因敲除小鼠血浆中的三甲基胺 N-氧化物浓度。
Sci Rep. 2018 Oct 3;8(1):14752. doi: 10.1038/s41598-018-33018-5.
9
Choline Supplementation Does Not Promote Atherosclerosis in CETP-Expressing Male Apolipoprotein E Knockout Mice.补充胆碱不会促进载脂蛋白 E 基因敲除 CETP 表达雄性小鼠的动脉粥样硬化。
Nutrients. 2022 Apr 15;14(8):1651. doi: 10.3390/nu14081651.
10
Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.血浆中氧化三甲胺的水平可能会因“健康”和“不健康”的饮食而升高,它与动脉粥样硬化的严重程度无关,而是与斑块的不稳定性有关。
Cardiovasc Res. 2021 Jan 21;117(2):435-449. doi: 10.1093/cvr/cvaa094.

引用本文的文献

1
Multi-omics integration reveals functional signatures of gut microbiome in atherosclerosis.多组学整合揭示了肠道微生物群在动脉粥样硬化中的功能特征。
Gut Microbes. 2025 Dec;17(1):2542384. doi: 10.1080/19490976.2025.2542384. Epub 2025 Aug 10.
2
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases.肠-心轴:揭示肠道微生物群在心血管疾病中的作用
Front Cardiovasc Med. 2025 May 26;12:1572948. doi: 10.3389/fcvm.2025.1572948. eCollection 2025.
3
Development of Next Generation Probiotics for Cardiometabolic Diseases.

本文引用的文献

1
The gut microbiome in atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病中的肠道微生物群
Nat Commun. 2017 Oct 10;8(1):845. doi: 10.1038/s41467-017-00900-1.
2
Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids.围产期高胆固醇血症通过改变氧化三甲胺和胆汁酸的代谢加重子代动脉粥样硬化病变。
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2053-2063. doi: 10.1161/ATVBAHA.117.309923. Epub 2017 Sep 21.
3
Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.
用于心脏代谢疾病的下一代益生菌的研发。
Phenomics. 2025 Mar 21;5(1):18-22. doi: 10.1007/s43657-025-00230-z. eCollection 2025 Feb.
4
The gut-heart axis: a review of gut microbiota, dysbiosis, and cardiovascular disease development.肠道-心脏轴:肠道微生物群、生态失调与心血管疾病发展综述
Ann Med Surg (Lond). 2025 Jan 9;87(1):177-191. doi: 10.1097/MS9.0000000000002789. eCollection 2025 Jan.
5
Gut microbiota and atrial cardiomyopathy.肠道微生物群与心房心肌病
Front Cardiovasc Med. 2025 Feb 4;12:1541278. doi: 10.3389/fcvm.2025.1541278. eCollection 2025.
6
Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.靶向肠道微生物群以调节动脉粥样硬化中的适应性免疫反应。
Front Cardiovasc Med. 2025 Jan 31;12:1502124. doi: 10.3389/fcvm.2025.1502124. eCollection 2025.
7
The role of the early-life gut microbiome in childhood asthma.早期肠道微生物群在儿童哮喘中的作用。
Gut Microbes. 2025 Dec;17(1):2457489. doi: 10.1080/19490976.2025.2457489. Epub 2025 Jan 30.
8
The gut microbiota in thrombosis.血栓形成中的肠道微生物群
Nat Rev Cardiol. 2025 Feb;22(2):121-137. doi: 10.1038/s41569-024-01070-6. Epub 2024 Sep 17.
9
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis.早期间歇性高脂血症会使组织巨噬细胞发生改变,从而促进动脉粥样硬化的发生。
Nature. 2024 Oct;634(8033):457-465. doi: 10.1038/s41586-024-07993-x. Epub 2024 Sep 4.
10
Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study.动脉粥样硬化性心血管疾病与炎症的研究态势:一项文献计量学与可视化研究
Rev Cardiovasc Med. 2022 Sep 14;23(9):317. doi: 10.31083/j.rcm2309317. eCollection 2022 Sep.
循环三甲基胺 N-氧化物与心血管疾病风险:11 项前瞻性队列研究的系统评价和荟萃分析。
J Cell Mol Med. 2018 Jan;22(1):185-194. doi: 10.1111/jcmm.13307. Epub 2017 Aug 7.
4
Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.罗伊氏乳杆菌DSM 17938对2型糖尿病患者的代谢影响:一项随机对照试验。
Diabetes Obes Metab. 2017 Apr;19(4):579-589. doi: 10.1111/dom.12861. Epub 2017 Feb 7.
5
Role of gut microbiota in atherosclerosis.肠道微生物群在动脉粥样硬化中的作用。
Nat Rev Cardiol. 2017 Feb;14(2):79-87. doi: 10.1038/nrcardio.2016.183. Epub 2016 Dec 1.
6
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.胆汁酸与肠道微生物群的相互作用及其对宿主代谢的影响。
Cell Metab. 2016 Jul 12;24(1):41-50. doi: 10.1016/j.cmet.2016.05.005. Epub 2016 Jun 16.
7
Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.氧化三甲胺通过丝裂原活化蛋白激酶和核因子-κB信号传导促进血管炎症
J Am Heart Assoc. 2016 Feb 22;5(2):e002767. doi: 10.1161/JAHA.115.002767.
8
Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism.膳食脂质与肠道微生物群之间的相互作用调节肝脏胆固醇代谢。
J Lipid Res. 2016 Mar;57(3):474-81. doi: 10.1194/jlr.M065847. Epub 2016 Jan 18.
9
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.肠道微生物三甲胺生成的非致死性抑制用于动脉粥样硬化的治疗
Cell. 2015 Dec 17;163(7):1585-95. doi: 10.1016/j.cell.2015.11.055.
10
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.依折麦布联合辛伐他汀使双重低密度脂蛋白胆固醇和高敏 C 反应蛋白目标达标更频繁,并改善 IMPROVE-IT 结局。
Circulation. 2015 Sep 29;132(13):1224-33. doi: 10.1161/CIRCULATIONAHA.115.018381. Epub 2015 Sep 1.